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Spontaneous cell deathQuinolinate phosphoribosyl transferase (QPRT) is a key enzyme in de novo NAD+ synthesis. QPRT enzyme
activity has a restricted tissue distribution, although QPRT mRNA is expressed ubiquitously. This study was
designed to elucidate the functions of QPRT protein in addition to NAD+ synthesis. QPRT was identiﬁed as a
caspase-3 binding protein using double layer ﬂuorescent zymography, but was not a substrate for caspase-3.
Surface plasmon resonance analysis using recombinant proteins showed interaction of QPRT with active-
caspase-3 in a dose dependent manner at 55 nM of the dissociation constant. The interaction was also
conﬁrmed by immunoprecipitation analysis of actinomycin D-treated QPRT-FLAG expressing cells using anti-
FLAG-agarose. QPRT-depleted cells showed increased sensitivity to spontaneous cell death, upregulated
caspase-3 activity and strong active-caspase-3 signals. Considered together, the results suggested that QPRT
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NAD+ is an essential cofactor of oxidation–reduction reac-
tions [1,2], and is synthesized through two pathways: de novo
synthesis and the salvage pathway [3,4]. While the latter activity is
found in all tissues, de novo synthesis of NAD+ has a restricted tissue
distribution that includes the liver and kidney. This distribution
mirrors the restricted enzyme activity of quinolinate phosphoribosyl
transferase (QPRT, EC.2.4.2.19), a key enzyme in de novo NAD+
synthesis, despite QPRT mRNA being expressed ubiquitously (see
Supplementary Table S1) [5,6]. NAD+ activity has been implicated in
various cellular functions such as anti-oxidative activity, calcium
homeostasis, gene expression, and apoptosis [7]. NAD+ is a substrate
for poly(ADP-ribose) polymerase (PARP)-1 whose products are
involved in both cell survival and apoptosis [8–10], and for sirtuins,
NAD+-dependent deacetylases involved in cell survival [11]. In-
creased nuclear NAD+ prevents axonal degeneration [12], while
overconsumption of NAD+ causes ATP depletion resulting in necrosis
[13]. Thus, the control of cellular NAD+ level is important for many
biological systems.Apoptosis plays a pivotal role in development, immune responses,
and certain pathological processes [14–16]. The caspase family of
large cysteine proteases includes several important players in
apoptosis and inﬂammation. Caspases involved in apoptosis are
divided into two groups: the initiator and the executioner caspases
[17]. There are many inhibitors of apoptosis, such as the Bcl-family
proteins that regulate cytochrome C release [18]. Some inhibitors of
apoptosis protein (IAPs) directly inhibit caspases and regulate
procaspase levels via their ubiquitin ligase activity [19]. Heat shock
proteins (HSPs) also regulate apoptosis at various stages: pre-
mitochondrial, during procaspase activation, and after caspase
activation [20,21]. These inhibitors also act in both spontaneous cell
death and signal-induced apoptosis [22]. Caspase-3 is particularly
important in apoptosis, acting in both intrinsic and extrinsic pathways
[17]. It is also essential for DNA fragmentation and nuclear
morphological changes that characterize apoptosis, although cas-
pase-3 is activated in the cytoplasm [23]. By cleaving PARP-1,
intranuclear active-caspase-3 suppresses the exhaustion of ATP that
leads to necrosis [8,24]. Thus, caspase-3 acts not only as an inducer of
apoptosis, but also as a suppressor of necrosis.
This study found that QPRT interacts with active-caspase-3, and
that depletion of QPRT protein increased intracellular caspase-3
activity. The QPRT-depleted cells were highly sensitive to spontane-
ous cell death than wild-type cells. Thus, QPRT protein prevented
spontaneous cell death through inhibition of overproduction of
active-caspase-3.
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2.1. Construction of plasmid vectors
The cDNA for human QPRT was ampliﬁed with the primer set
(CAGACAGCTGCAAGTCACCATGGAC and TGAAGTCAGCCCTGACAGGT-
CACAG) from a human brain cDNA library (OriGene, Rockville, MD).
Nested PCR was carried out using the ﬁrst PCR sample diluted 1:1000
as a template with the 2nd primer set (CGGGAATTCCACCATG-
GACGCTGAAGGCCTGGCGC and GCCGGATC––—————CTCGAGGTGGATTTTGGG-
CACTGGAGC, underlines and double underline indicated EcoRI,
BamHI, and XhoI site, respectively). These primer sets were designed
from the nucleotide sequence of human QPRT cDNA (BT007231.1).
After digestionwith EcoRI and BamHI, the QPRT cDNAwas ligated into
p3xFLAG-CMV-14 (Sigma-Aldrich, Inc., St. Louis, MO) and designated
as p3xFLAG-QPRT. Alternatively, after digestion with EcoRI and XhoI,
that was inserted into pET21b (Novagen, Gibbstown, NJ) and
designated as pET-QPRT. A termination codon was inserted into
pET-QPRT using Quick Change™ (Stratagene, La Jolla, CA) with
forward and reverse terminator primers set (CCCAAAATCCACTAGCT-
CAGACACCAC and GTGGTGCTCGAGCTAGTGGATTTTGGG), and desig-
nated as pET-QPRT-Ter.
The cDNA for human procaspase-3 was ampliﬁed with the primers
set (GCGGCATATGGAGAACACTGAAAACTCAGT and GCGGGATCCGGGT-
GATAAAAATAG, underlines indicated NdeI and BamHI, respectively)
from a human liver cDNA library (Origene, Rockville, MD). These
primers were designed from the nucleotide sequence of human
procaspase-3 (NP_116786.1). After digestion with NdeI and BamHI,
cDNAwas inserted into pET21b. Nucleotide sequences of the expression
vectors were conﬁrmed byHokkaido System Sciences (Sapporo, Japan).
2.2. Identiﬁcation and puriﬁcation of active-caspase-3-interacting
proteins
Double-layer ﬂuorescent zymography (DLFZ) was carried out as
described previously [25]. Brieﬂy, samples were subjected to SDS-
PAGE without dithiothreitol (DTT) or heat-treatment. After washing
with 2.5% Triton X-100 for 30 min followed by immersion in 5 mM
Tris–HCl (pH 8.0) and 50 μM caspase-3 (Calbiochem, San Diego, CA),
the gels were covered with a cellulose acetate membrane treated with
100 mM Tris–HCl, 10% glycerol and 100 μM Acetyl-L-aspartyl-L-
glutamyl-L-valyl-L-aspartic acid α-4-methylcoumaryl-7-amide (Ac-
DVED-MCA). After incubation at 37 °C for 15–30 min, the released 7-
amino-4-methylcoumarin (AMC) with the proteins that interacted
with active-caspase-3 were visualized on the ultraviolet trans-
illuminator (UVP, Upland, CA) at wavelength of 360 nm.
Bovine liver was homogenized in 10 mM Tris–HCl (pH 7.5) and
0.25 M sucrose with a glass-Teﬂon homogenizer. The samples were
prepared as follows; the homogenate was centrifuged at 17,400 ×g for
30 min, and the supernatant was subjected to ultracentrifugation at
100,500 ×g for 1 h. The supernatant was heat treated at 55 °C for
1 min, and then centrifuged at 17,400 ×g for 30 min. The supernatant
was precipitated in 30% ammonium sulfate. The precipitate was
dissolved in Tris-buffered saline (TBS) composed of 20 mM Tris–HCl
(pH 7.5) and 150 mM NaCl, and then fractionated through Sephadex
G75. The fractions containing caspase-3-interacting proteins identi-
ﬁed by DLFZwere dialyzed against 20 mMTris–HCl (pH 7.5), and then
subjected to Mono-Q chromatography (GE Healthcare, Uppsala,
Sweden). The eluant (in 0.3 M NaCl) was concentrated and fraction-
ated through Superdex-75 (300GL). The caspase-3 interacting protein
bands in SDS-gels were subjected to trypsin digestion and nano-liquid
chromatography (LC)-MS/MS (HCT-PLUS, Brucker-Daltonics, Bill-
erica, MA) using the protocol provided by the manufacturer. The
MS/MS data were analyzed by the MASCOT server software (Matrix
Science, Yokohama, Japan). The active-caspase-3-interacting proteins
were then fractionated on a preparative SDS-gel after heat-denatur-ation in the presence of 10 mM DTT (Nihon Eido, Tokyo, Japan). The
puriﬁed samples were subjected to SDS-PAGE and blotting onto
Immobilon-P membrane (Millipore, Bedford, MA). The protein band
corresponding to caspase-3-interacting proteins was excised and
subjected to trypsin digestion and amino acid sequencing (APRO
Science Co., Tokushima, Japan).
2.3. Puriﬁcation and interaction of recombinant QPRT and caspase-3
Recombinant human QPRT was puriﬁed from the BL21(DE3)-RIPL
Codon Plus (Stratagene) bearing pET21-QPRT-Ter. In brief, the cells
were cultured in Luria broth with ampicillin until OD600=1.0. Then,
IPTG was added to a ﬁnal concentration of 0.4 mM. After a 16-
h induction at 20 °C, the cells were centrifuged and disrupted in
phosphate-buffered saline (PBS) composed of 20 mM sodium phos-
phate buffer (pH 7.2) and 150 mM NaCl using a French Press.
Following centrifugation at 10,000 ×g for 15 min, the supernatants
were subjected to 0–30% ammonium sulfate precipitation. The
precipitates were resuspended in 0.1 M Tris–HCl (pH 7.5), and
applied to a Blue-Sepharose™ column (GE Healthcare) to remove
bacterial proteins. The ﬂow-through sample was applied to a Mono-Q
column, washed with 50 mM Tris–HCl (pH 7.5) and eluted with a
linear gradient from 0 to 0.5 M NaCl. Recombinant QPRT was eluted in
fractions containing 0.2–0.3 M NaCl.
To purify the recombinant caspase-3, the expression vector
bearing BL21 (DE3)-RIPL Codon Plus was cultured in Circle Grow
(Bio101) medium until OD600=2.0 (measured by spectrophotom-
etry after 2-fold dilution with uncultured medium). The protein was
then induced by adding 1 mM IPTG for 3 h at 25 °C. The cells were
harvested and suspended in 10 mM Tris–HCl (pH 8.5), 20 mM
imidazole, 1 mM Phenylmethylsulfonyl ﬂuoride (PMSF), and 1 mM
DTT, and then disrupted using a French Press. After centrifugation at
15,000 rpm for 30 min, the supernatant was applied to Ni-sepharose.
After extensive washing with 10 mM Tris–HCl (pH 8.5) containing
20 mM imidazole, the samples were eluted with 0.5 M imidazole in
10 mMTris–HCl buffer (pH 8.5). After dialysis against 10 mMTris–HCl
buffer (pH 8.5), the samples were loaded onto a Mono-Q column,
washed with 50 mM Tris–HCl (pH 7.5) and eluted with a linear
gradient from 0 to 0.5 M NaCl. Recombinant caspase-3 was eluted in
fractions containing 0.2–0.3 M NaCl.
The puriﬁed recombinant QPRT was adjusted to 1.0 mg/ml and
immobilized on a CM-5 sensor chip (GE Healthcare) in 10 mM acetate
buffer (pH 5.5). The sensor chip was primed with HEPES-KOH buffer
(pH 7.4) containing 160 μM KCl according, as recommended by the
manufacturer. The sample containing the recombinant caspase-3
(18.75 nM, 37.5 nM, 75 nM, 150 nM, and 300 nM)was analyzed in the
BIAcore 3000 system at a ﬂow rate of 20 μl/min. Dissociation
constants were calculated using the computer package, BIA Evaluation
ver. 4.1, in accordance with the instructions supplied by the
manufacturer (GE Healthcare).
2.4. Cell culture and related analyses
HeLa cells were cultured in Dulbecco's modiﬁed Eagle medium
supplemented with 10% fetal bovine serum and antibiotic–antimyco-
tic (Nacalai Tesque, Kyoto, Japan) in a humidiﬁed atmosphere with 5%
CO2 at 37 °C. HeLa cells were cultured in 3.5-cm dishes (2.0×105
cells/dish) and transfected with either small interfering RNA (siRNA)
for QPRT (guggcaggcacgaggaagcTT and ucuuccucgugccugccacTT) or
scramble RNA (srRNA, cgcgaaagaagggcguaggTT and ccuacgcccuu-
cuuucgcgTT) and/or p3xFLAG-QPRT (1 μg) using Xtreme Gene siRNA
(Roche Diagnostics, Mannheim, Germany) according to the instruc-
tions provided by the manufacturer. These RNAs were designed and
then synthesized in B-Bridge Science (Tokyo). After 24 h in culture,
the cells were inoculated in 96-well culture plates at 2.5×103 cells/
well. Thirty-two hours later, the cells were treated with 12.5 μM
Fig. 1. Puriﬁcation and amino acid sequencing of caspase-3-interacting protein.
A. Caspase-3-interacting protein was puriﬁed by gel ﬁltration, anion-exchange
chromatography, and 2nd-gel ﬁltration. The samples of the 2nd-gel ﬁltration (fraction
11 at peak fraction) were subjected to 12.5% SDS-PAGE followed by CBB staining (left
panel) or DLFZ (right panel). Stars: caspase-3-interacting protein. Results are
representative of ﬁve independent experiments. B. Amino acid sequence analysis
identiﬁed a 37-kDa protein as QPRT. Amino acid sequence of bovine QPRT is arranged.
Amino acid sequences of the peptides derived from the puriﬁed protein determined by
ESI-MS/MS are underlined and by the amino acid sequencer are italicized. Overall,
27.1% of the amino acid sequences of the 37-kDa caspase-3-interacting protein were
also identiﬁed the bovine QPRT.
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Medics, Tokyo), or dimethyl sulfoxide (DMSO) alone for 16 h. The
dead cells were counted using an LDH-cytotoxic kit (Wako Pure
Chemicals, Osaka, Japan). The remaining cells were cultured for 36 h,
then subjected for analysis of ATP content, total NAD and NADH
contents, and caspase-3 activity. Cellular ATP content, and total NAD
and NADH contents were measured using ATP Colorimetric/Fluoro-
metric Assay kit, and NAD+/NADH Quantiﬁcation kit, respectively
(BioVision, Mountain View, CA). Caspase-3 activity was measured as
described previously [26]. In brief, 50 μg of a cell lysate obtained by
cells disrupted in PBS by sonication, in 200 μl of the assay buffer
composed of 100 mM Tris–HCl (pH 7.5), 10 mM DTT, 1 × Protease
Inhibitor Cocktail (PIC, 1 mM 4-(2-aminoethyl)benzenesulfonyl ﬂuo-
ride hydrochloride, 0.8 μM aprotinin, 15 μM E-64, 20 μM leupeptin
hemisulfate monohydrate, 50 μM bestatin, and 10 μM pepstatin A,
Nacalai Tesque), and 200 μM Ac-DEVD-MCA were incubated at 37 °C.
At each time point, the amount of released AMC was measured in a
ﬂuorescent microplate reader at an excitation wavelength of 370 nm
and emission wavelength of 460 nm (MTP-100F, Corona, Hitachinaka,
Japan). The remaining samples weremixedwith PIC, 100 μMAcetyl-L-
aspartyl-L-glutamyl-L-valyl-L-aspart-1-al (Ac-DEVD-CHO), and
100 μM Acetyl-L-leucyl-L-glutamyl-L-histidyl-L-aspart-1-al (Ac-
LHDV-CHO), and then subjected to SDS-PAGE and immunoblotting
using antibodies against QPRT (IgY, 2 μg/ml, Genway, San Diego, CA)
and α-tubulin (×1000, clone DM1A, Sigma-Aldrich).
For immunoprecipitation of QPRT-FLAG, HeLa cells were inoculated
in 10-cm dishes at 1.0×106 cells/dish. After 48 h, 10 μg p3xFLAG-QPRT
or p3xFLAG-CMV-14 was transfected using FuGENE HD (Roche
Diagnostics) according to the instructions provided by the manufactur-
er. After 48 h in culture, the cells were treatedwith either DMSO for 8 h,
or DMSO for 4 h and then, 12.5 μM actinomycin D for 4 h or 12.5 μM
actinomycin D for 8 h. The cells were lysed in IP buffer containing PBS
plus 0.5% Nonidet® P-40 (Nacalai Tesque), 0.05% SDS, PIC, 100 μM Ac-
DEVD-CHO, and 100 μM Ac-LHVD-CHO. After centrifugation at
18,500 ×g for 15 min, the samples were incubated with nonimmune
mouse IgG plus protein-G-agarose for 1 h, and then centrifuged at
5000 ×g for 5 min. The supernatant was mixed with anti-FLAG(M2)-
agarose (Sigma-Aldrich), rotated gently at 4 °C for 16 h, and then
centrifuged at 5000 ×g for 5 min. The precipitates were extensively
washed with PBS three times, and then subjected to 13% SDS-PAGE and
immunoblotting with anti-QPRT antibody, anti-procaspase-3 antibody
(1 μg/ml, clone 19, BD Biosciences, Franklin Lakes, NJ), and anti-active-
caspase-3 antibody (2 μg/ml, rabbit polyclonal IgG, Chemicon Interna-
tional Inc., Temecula, CA). The reactive bands were detected with HRP-
conjugated secondary antibodies (ICN Biomedicals, Aurora, OH) and
visualized using Immobilon Western™ (Millipore) in LAS-3000 mini-
system (Fuji Film, Tokyo, Japan).
2.5. Immunocytochemical analysis of QPRT-depleted HeLa cells
Transfected HeLa cells were cultured for 32 h on cover slips, and
then ﬁxed in 3.7% formaldehyde at 37 °C for 15 min and permeabi-
lized in TBS containing 0.1% Triton X-100 on ice for 5 min. The samples
were reacted with anti-active-caspase-3 antibody (4.0 μg/ml) and
anti-QPRT antibody (2.0 μg/ml) at 4 °C for 16 h, and then incubated in
TRITC-conjugated anti-rabbit-IgG antibody (1:5000, ICN Biomedicals)
and FITC-conjugated anti-IgY antibody (1:1000, ICN Biomedicals) in
the presence or absence of 4′6′-diamidino-2-phenylindole dihy-
drochloride (DAPI, 25 μg/ml, Nacalai Tesque) at room temperature
for 1 h with gentle agitation. Alternatively, the samples were directly
stained with annexin V-ﬂuorescein and propidium iodide using
annexin-V-FLUOS staining kit (Roche Diagnostics). The samples
were mounted on slide glasses using Aqua/Polymount (Polysciences,
Warrington, PA) and observed on a Leica TSC NT confocal microscope
(Leica Instruments, Nusslosh, Germany) or ﬂuorescence microscope
(model BIOREVO BZ-9000, Keyence, Osaka).2.6. Statistical analysis
Values were expressed as mean±SD or SEM. Differences between
groups were examined for statistical signiﬁcance using the Mann–
Whitney's U-test. A P-value less than 0.05 was considered statistically
signiﬁcant. All analyses were conducted using the Excel-Statistics
software (SSRI, Tokyo).
3. Results
3.1. Puriﬁcation and identiﬁcation of active-caspase-3-interacting
proteins in the cytoplasm of hepatocytes
DLFZ is a useful method to screen for protease-interacting proteins
[25]. In a previous study, we identiﬁed a caspase-3-interacting protein
as senescence marker protein-30. To identify other active-caspase-3-
interacting proteins in the liver cytoplasm in this study, we puriﬁed a
37-kDa candidate protein from an SDS-gel (Fig. 1A). In-gel digestion
of the 37-kDa protein with trypsin followed by nano-LC-ESI-MS/MS
identiﬁed the amino acid sequences of bovine QPRT (27.1% of its
amino acid sequences were identiﬁed, see Fig. 1B, underlined
sequences), ketol-acid reductoisomerase (3% were identiﬁed), and
δ-aminolevulinic acid dehydratase (3% were identiﬁed). Furthermore,
the samples were also subjected to SDS-PAGE, after interaction with
caspase-3 using DLFZ, then to trypsin digestion and amino acid
sequencing. Two amino acid sequences of the tryptic peptides were
530 K. Ishidoh et al. / Biochimica et Biophysica Acta 1803 (2010) 527–533identiﬁed in bovine QPRT (Fig. 1B, see amino acid sequence in italic
letters). Overall, 27.1% of amino acid sequence of 37-kDa caspase-3-
interacting proteins was identical to that of bovine QPRT. Thus, we
identiﬁed this 37-kDa caspase-3-interacting protein as QPRT.
3.2. Interaction of recombinant human QPRT with caspase-3
The nucleotide sequences of cDNAs of both human QPRT and
procaspase-3 used in this study were identical to those of UniGene
database (human QPRT; Hs.513484 and human procaspase-3;
Hs.141125, respectively). In particular, we isolated two types of
cDNA clones for human QPRT whose deduced amino acid sequence
contained either Val-53 or Ile-53, and we used the Val-53 form in the
following studies (see Fig. S1).
Both recombinant QPRT and procaspase-3 were puriﬁed to near
homogeneity (Fig. 2A). Recombinant procaspase-3 was autocatalyt-
ically processed into its lowmolecular weight forms, consistent with aFig. 2. Recombinant QPRT bound to active-caspase-3 in vitro. A. Puriﬁed recombinant
QPRT and active-caspase-3 were electrophoresed by SDS-PAGE and stained with silver
(lane 1: 0.1 μg of QPRT incubated at 37 °C for 16 h, lane 2: 1 μg of active-caspase-3
incubated at 37 °C for 16 h, lane 3: 0.1 μg of QPRT and 1 μg of active-caspase-3 without
incubation, and lane 4: 0.1 μg of QPRT and 1 μg of active-caspase-3 incubated at 37 °C
for 16 h in 0.1 M Tris–HCl, 10 mMDTT, pH 7.5). Arrowheads on the left side of the panel
indicate the molecular weight markers. Results are representative of three independent
experiments. B. QPRT interacts with active-caspase-3 in vitro. Results of the surface
plasmon resonance analyses at various concentrations of active-caspase-3 (300, 150,
75, 37.5, and 18.75 nM) on the QPRT-conjugated sensor chip. The association and
dissociation described above the proﬁle were set in the BIA Evaluation as parameters.
Representative data of similar results of three independent experiments.previous report [27]. The processed caspase-3 was stable at 4 °C for
more than 72 h with a speciﬁc activity of 18.1 nmol of released AMC/
ng/min, which is 25-fold higher than that of the commercially
available recombinant caspase-3 used in DLFZ studies. This sample
was therefore used as the active-caspase-3. To investigate whether
QPRT is a substrate for caspase-3, we incubated QPRT with active-
caspase-3 for 16 h at 37 °C. The amounts of QPRT in the samples
incubated with or without active-caspase-3 were comparable and no
degradation product of QPRT was detected in the sample (Fig. 2A).
These results indicate that QPRT itself is not a substrate for active-
caspase-3. There is no consensus amino acid sequence of caspase-3
cleavage site (e.g., Asp-Glu-Val-Asp) in human QPRT amino acid
sequence. Thus, this ﬁnding was in agreement with the prediction
from human QPRT amino acid sequence. In addition, caspase-3
activity did not change in the presence or absence of QPRT protein at
baseline and after a 16-h incubation (baseline caspase-3-activity,
without QPRT: 18.1, with QPRT: 16.5 nmol of released AMC/ng/min,
after 16 h without QPRT protein: 16.2, with QPRT: 14.8 nmol of
released AMC/ng/min).
The interaction of QPRT and active-caspase-3 was then analyzed
using the BIAcore3000 system (Fig. 2B). Active-caspase-3 tightly
bound with QPRT in vitro, and the amount of bound caspase-3 on the
QPRT-conjugated sensor chip increased dose-dependently. The
calculated dissociation constant of the interaction using the BIA
Evaluation ver. 4.1 was 55 nM.
3.3. Interaction of QPRT and active-caspase-3 in cells
Next, to conﬁrm the results of DLFZ and surface Plasmon resonance
analyses using recombinant proteins, immunoprecipitation analyses
using HeLa cells treated with actinomycin D, an inducer of apoptosis,
were performed. Treatment with actinomycin D reduced the amount
of procaspase-3 and conversely increased that of active-caspase-3 in
HeLa cells (Fig. 3). At ﬁrst, we used one IgY- and two clones of mouse
monoclonal IgG-antibodies against QPRT obtained from Genway.
Although the QPRT protein was precipitated from HeLa cells lysates
treated with or without actinomycin D using these antibodies, active-
caspase-3 was not detected in the immunoprecipitates prepared from
HeLa cells treated with actinomycin D for 4 h. It is possible that these
antibodies masked the interacting regions of QPRT with active-
caspase-3 molecule. To check such possibility, we treated p3xFLAG-
QPRT-transfected HeLa cells with anti-FLAG-antibody. QPRT-FLAG
was precipitated from QPRT-FLAG-expressing cells treated with
actinomycin D using M2-agarose (Fig. 3, upper panel). Procaspase-3Fig. 3. Interaction of QPRT and active-caspase-3 in cells. Coimmunoprecipitation
analyses of p3xFLAG-QPRT-transfected HeLa cells with anti-FLAG-agarose. Either
p3xFLAG-CMV-14, an expression vector purchased from Sigma-Aldrich, or p3xFLAG-
QPRT-transfected cells treated with 0.5% DMSO plus 12.5 μM actinomycin D for 8 h (the
numbers above panels indicate the time of actinomycin D treatment) were subjected to
immunoprecipitation analysis. Aliquots of total cell lysates (Input), immunoprecipi-
tates (Bound), and aliquots of unbound samples (Unbound) were electrophoresed on
13% SDS-gels, followed by immunoblotting for QPRT (upper panel), procaspase-3
(middle panel), and active-caspase-3 (lower panel). Representative data of similar
results of three independent experiments.
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However, active-caspase-3 was detected in precipitates from QPRT-
FLAG-transfected cells treated with actinomycin D for 4 h (lower
panel). Thus, QPRT protein interacts with active-caspase-3 in HeLa
cells treated with actinomycin D for 4 h.
3.4. Depletion of QPRT increases cell death
To clarify the role of QPRT in cell death, HeLa cells depleted of QPRT
using siRNA were prepared. The levels of QPRT proteins in HeLa cells
transfected with siRNA or p3xFLAG-QPRT were depleted or increased,
respectively, compared to MOCK-transfected cells or srRNA-trans-
fected cells (Fig. 4A). Transfection of srRNA did not affect cellular
QPRT protein content. Cotransfection of p3xFLAG-QPRT and siRNA for
QPRT depleted both endogenous QPRT protein and QPRT-FLAG.
Next, to evaluate the effect of QPRT protein on the cellular energy
state, we measured ATP content, total NAD (NAD+ plus NADH) and
NADH contents in QPRT-depleted and QPRT-expressing HeLa cells
(Fig. 4B). Depletion or expression of QPRT did not alter the total NAD
content, whereas both tended to increase NADH content. Calculated
from these results, the ratios of NADH to NAD+ tended to increase in
both QPRT-depleted and -expressing cells. In addition, the ATP
contents in QPRT-depleted and -expressing HeLa cells also tendedFig. 4. Effects of depletion of QPRT on cellular energy state. A. Immunoblot analyses of
QPRT and α-tubulin in either siRNA or scramble RNA (srRNA)- and/or p3xFLAG-QPRT-
transfected cells. Twenty-ﬁve micrograms of total cell lysate was subjected to 12.5%
SDS-PAGE and immunoblotting for QPRT and α-tubulin. Representative data of similar
results of three independent experiments. The nucleotide sequences for siRNA and
srRNA are presented under the panels. B. Total NAD (NAD+ plus NADH), NADH con-
tents and ATP content in QPRT-depleted and expressing cells. Total NAD and NADH in
MOCK-, siRNA-, and p3xFLAG-QPRT-transfected cells were measured. Data are mean±
SEM (n=4). The ratio of NADH per NAD+ was calculated using the mean values.
Differences between the groups were not signiﬁcant (Mann–Whitney's U-test).
Representative data of similar results of three independent experiments.to be higher than in mock-transfected cells. Depletion of QPRT more
effectively increased both NADH and ATP contents than expression of
QPRT, compared with mock-transfected cells, although these differ-
ences were not signiﬁcant by the Mann–Whitney's U-test.
To clarify the changes in caspase-3 activity, we measured caspase-
3 activity in total cell extracts prepared from the transfected cells.
Caspase-3 activity signiﬁcantly increased in siRNA-transfected cells
even in the absence of apoptosis inducers (Fig. 5A). Caspase-3 activity
was slightly detectable in p3xFLAG-QPRT-transfected cells. In con-
trast, caspase-3 activity was virtually absent from MOCK-transfected
cells. The difference in caspase-3 activity of either QPRT-depleted cells
or QPRT-expressing cells and that of MOCK-transfected cells was
signiﬁcant at 95% (P-value=0.0495), or not signiﬁcant (P-
value=0.2752) by Mann–Whitney's U-test, respectively.
Next, we evaluated the effect of siRNA on both spontaneous and
apoptosis inducer-mediated cell death (Fig. 5B). Cells transfected with
siRNA showed increased activities of released LDH with and without
apoptosis inducers, actinomycin D, and staurosporine, compared to
MOCK-transfected cells. These differences were signiﬁcant at 99% (P-
value=0.0007) by Mann–Whitney's U-test. The increased LDH
activity due to apoptosis inducers (mean LDH activity in actinomycin
D-treated cell minus that in DMSO-treated cells, and that in
staurosporine-treated cells minus that in DMSO-treated cells) in
siRNA-transfected cells was slightly more than that detected in
MOCK-transfected cells. In contrast, transfection of p3xFLAG-QPRT
into HeLa cells had no signiﬁcant effect on LDH activity with and
without apoptosis inducers.
Next, we used immunocytochemistry to analyze the effects of
siRNA for QPRT or p3xFLAG-QPRT expression on caspase-3 activation
(Fig. 5C). Active-caspase-3 was barely detectable in MOCK-trans-
fected cells, while the siRNA-transfected cells contained many large
and strong of active-caspase-3 signals. In contrast, the magnitude and
number of active-caspase-3-positive signals increased slightly only in
p3xFLAG-QPRT-transfected cells compared to MOCK-transfected
controls. These results correlated closely with the measured
caspase-3-activity in these cells (Fig. 4A). In addition, QPRT-signals
surrounded active-caspase-3 signals in p3xFLAG-QPRT-transfected
cells (see Fig. S2). To determine the type of cell death in QPRT-
depleted cells, DAPI staining was carried out (Fig. 5D). Based on the
pattern of DAPI staining, QPRT-depleted cells with many and large
active-caspase-3 positive signals contained condensed nuclei, which
are one of the hallmarks of apoptotic cells. Furthermore, annexin-V
and propidium iodide staining showed that cell death in both MOCK-
and p3xFLAG-QPRT-transfected cells was due to necrosis while that of
siRNA-transfected cells was due to apoptosis as well as necrosis even
in the absence of inducers of apoptosis (Fig. 5E). The increased LDH
activity in siRNA-transfected cells was in part due to increased
number of apoptotic cells in QPRT-depleted cells cultured in the
absence of apoptosis inducers.
4. Discussion
In this study, we showed that QPRT interacts with active-caspase-
3, and that depletion of QPRT increased caspase-3 activity resulting in
increased sensitivity to spontaneous cell death compared with wild-
type cells.
Depletion or expression of QPRT proteins did not alter the total
cellular NAD (Fig. 4B), suggesting that the de novo NAD synthesis
pathway is not active in HeLa cells as it is in many other tissues [6].
Changes in the amount of QPRT protein altered the intracellular ratio
of NADH per NAD+, as well as ATP contents. Depletion of QPRT tended
to have a larger inﬂuence on these changes than the expression of
QPRT. It was reported that increased ATP content is essential for
apoptosis, in particular, the step involving activation of procaspase-3
[28]. Increased ATP content in QPRT-depleted cells was probably
sufﬁcient by itself to activate caspase-3 and to induce apoptosis, while
Fig. 5. Depletion of QPRT increased spontaneous cell death. A. Activity of caspase-3 in the transfected cells. Caspase-3 activities in MOCK-transfected cells, siRNA-transfected cells,
and p3xFLAG-QPRT-transfected cells. Data are mean±SEM of triplicate samples. Representative data of similar results of three independent experiments. B. The numbers of dead
cells were counted based on the activity of released LDH. Open, dark gray, and gray histograms represent LDH activity released from cells treated with DMSO, actinomycin D, and
staurosporine, respectively. Data are mean±SD (n=8). Representative data of similar results of three independent experiments. C–E. Immunocytochemical analysis of MOCK-,
siRNA- and p3xFLAG-QPRT-transfected cells. The cells were stained with QPRT (green) and active-caspase-3 (red) and viewed using a Leica TSC NT confocal laser microscope at 63×
magniﬁcation (C). The cells were stained with QPRT (green), active-caspase-3 (red) and DAPI (blue) and viewed using a BIOREVO BZ-9000 at 60× magniﬁcation (D). Necrotic cells
and apoptotic cells were stained with propidium iodide (red) and annexin V-ﬂuorescein (green), respectively, and viewed using a BIOREVO BZ-9000 at 20× magniﬁcation (E).
Arrows: apoptotic cells, arrowheads: necrotic cells.
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Alternatively, the changes in QPRT-expressing cells were sufﬁcient to
activate procaspase-3, but the large amounts of QPRT suppressed any
further activation that would be necessary to induce apoptosis. The
latter was more likely than the former because of the smaller caspase-
3 activity and active-caspase-3 signals in QPRT-expressing cells than
in QPRT-depleting cells (Fig. 5). These conclusions need to be
conﬁrmed in future studies.
Quinolinic acid (QA) is implicated in the neuronal cell death
characteristic of Huntington's disease (HD), known as an “excitotoxin
model” [29]. This hypothesis is supported by experimental studies
and increases in both QA and its metabolites in the striatum and
cortex of HD brain [30,31]. QPRT activity was also increased in HD
brain and in rat brain following QA injection [32]. It was also reported
that QA forced neuronal cells into necrosis, which was prevented by
inhibiting PARP-1 [33,34]. The results of the present study indicated
that accumulation of QPRT protein tended to increase cellular ATP
content. Upregulation of QPRT protein in QA-injected brain is possibly
one of the defense mechanisms against QA-induced necrosis of brain
tissue.
Database search for QPRT expression in tumor and normal tissues
suggested increased QPRT transcript in many tumors compared to
normal tissues (see Supplementary Table S1), and that overexpres-
sion of QPRT in tumors is probably a poor prognostic factor [35].
Cancer cells that are resistant to cell death signals proliferated and
ﬁnally formed cancer cell mass. In this regard, QPRT is not expressed
in prostatic cancer compared with very low expression in the normalprostate [5]. These data could probably explain the slower growth of
prostatic cancer, which could be related to apoptosis, than other
cancers [36]. Further studies are needed to investigate this issue in
more detail.
Caspase-3-interacting proteins have also been implicated in the
suppression of apoptosis. Speciﬁcally, HSP-27 suppresses the proces-
sing of procaspase-3 [37], while cIAP-1 inhibits activated caspase-3
[19], and HSP-70 retained active-caspase-3 away from its substrates
[38]. In addition, QPRT interacted with spontaneously activated
caspase-3, resulting in suppression of increases in active-caspase-3
activity. This suppression is a possible alternative mechanism of cell
death suppression by spontaneously activated caspase-3. Colocaliza-
tion of QPRT-positive signals around active-caspase-3-positive signals
in p3xFLAG-QPRT-transfected cells (whose sensitivity to spontaneous
cell death is comparable to that of MOCK-transfected cells), also
supports this hypothesis (see Fig. S2).
The present results demonstrated that QPRT interacts with active-
caspase-3. Depletion of QPRT resulted in increases in active-caspase-3
with a resultant increase in spontaneous cell death. Such a role poses
an alternative function for QPRT protein in addition to its key role in
de novo NAD+ synthesis.
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